美国 - 英文 - NLM (National Library of Medicine)

marlex pharmaceuticals, inc. - selegiline hydrochloride (unii: 6w731x367q) (selegiline - unii:2k1v7gp655) - selegiline hydrochloride capsules, usp are indicated as an adjunct in the management of parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. there is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy. evidence supporting this claim was obtained in randomized controlled clinical investigations that compared the effects of added selegiline or placebo in patients receiving levodopa/carbidopa. selegiline was significantly superior to placebo on all three principal outcome measures employed: change from baseline in daily levodopa/carbidopa dose, the amount of 'off' time, and patient self-rating of treatment success. beneficial effects were also observed on other measures of treatment success (e.g., measures of reduced end of dose akinesia, decreased tremor and sialorrhea, improved speech and dressing ability and improved overall disability as assessed by wal

美国 - 英文 - NLM (National Library of Medicine)

mylan specialty l.p. - selegiline (unii: 2k1v7gp655) (selegiline - unii:2k1v7gp655) - selegiline 6 mg in 24 h - emsam (selegiline transdermal system) is a monoamine oxidase inhibitor (maoi) indicated for the treatment of adults with major depressive disorder (mdd) [see clinical studies (14)] . the available data on emsam use in pregnant women are not sufficient to inform a drug-associated risk of adverse pregnancy-related outcomes. in animal embryo-fetal development studies, transdermal administration of selegiline to rats and rabbits at doses up to 60 and 64 times the maximum recommended human dose (mrhd) respectively, produced slight increases in malformations in both rats and rabbits, and decreased fetal weight, delayed ossification, and embryo-fetal post-implantation loss in rats. most of these effects were seen at the high dose in both rats and rabbits. these effects were not seen at 8 times and 16 times the mrhd in rats and rabbits, respectively. in a pre-natal and post-natal development study, transdermal administration of selegiline in rats at doses 8, 24, and 60 times mrhd produced a decrease in pup weight an

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

ratiopharm gmbh, ulm array - 2220 fentanyl - transdermální náplast - 100mcg/h - fentanyl

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

ratiopharm gmbh, ulm array - 2220 fentanyl - transdermální náplast - 12mcg/h - fentanyl

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

ratiopharm gmbh, ulm array - 2220 fentanyl - transdermální náplast - 25mcg/h - fentanyl

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

ratiopharm gmbh, ulm array - 2220 fentanyl - transdermální náplast - 50mcg/h - fentanyl

捷克共和国 - 捷克文 - SUKL (Státní ústav pro kontrolu léčiv)

ratiopharm gmbh, ulm array - 2220 fentanyl - transdermální náplast - 75mcg/h - fentanyl

加拿大 - 英文 - Health Canada

teva canada limited - selegiline hydrochloride - tablet - 5mg - selegiline hydrochloride 5mg - monoamine oxidase b inhibitors

加拿大 - 英文 - Health Canada

mylan pharmaceuticals ulc - selegiline hydrochloride - tablet - 5mg - selegiline hydrochloride 5mg - monoamine oxidase b inhibitors

德国 - 德文 - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ratiopharm gmbh (3087881) - selegilinhydrochlorid - tablette - selegilinhydrochlorid (21954) 5 milligramm